Hematological Malignancies

HL age distribution 15-20 years 15% 41-50 years 18%

HL treatment

other/un known 0%

Treatme nt category 0%

rt only 28%

rt & ct 60%

31-40 years 28%

21-30 years 39%

ct only 12%

41% anthracycline-containing chemotherapy Over time ↓ use mantle field and abdominal RT

Schaapveld, work in progress